Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

A new personalized mRNA melanoma vaccine developed by Moderna and Merck is showing promising results, cutting the risk of cancer recurrence nearly in half for high-risk patients.

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

On February 2, 2026, U.S. District Judge Joshua D. Wolson made several key summary judgment rulings in advance of trial in ...

Some periods of history are so bizarre that even if you’ve lived through them, looking back on them feels surreal, as though ...

A world-first trial in Australia will treat children with advanced brain cancer using technology from the COVID-19 jab.

Australia has launched the world’s first clinical trial testing personalized mRNA cancer vaccines in children suffering from ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

AT HIS NOMINATION hearing in January 2025, Robert F. Kennedy Jr. announced he’d “do everything in my power to put the health ...

National Institutes of Health (NIH) Director Jayanta Bhattacharya, M.D., Ph.D., spent much of a Senate committee hearing dancing around direct answers—except when it came to vaccines, a topic in which ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

Instagram account “Yup That Exists" provides its followers with the most peculiar and unique phenomena, inventions, and ...